Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Peroxisome (mmu04146)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Abcd1
KLA  ATP  ATP+KLA
 AF213385 ATP-binding cassette protein (Abcd1) mRNA, partial cds. [AF213385] KLA 1.01 1.10 1.02 .95 1.20 1.49 1.29
ATP 1.08 1.23 .96 1.22 .79 .70 1.15
KLA/ATP 1.13 1.16 .86 1.15 .85 .84 1.39
Abcd1
KLA  ATP  ATP+KLA
 NM_007435 ATP-binding cassette, sub-family D (ALD), member 1 (Abcd1), mRNA [NM_007435] KLA 1.00 .97 1.03 1.08 1.33 1.52 1.38
ATP 1.17 1.39 1.00 1.50 .86 .61 1.20
KLA/ATP 1.23 1.20 .90 1.17 .84 .84 1.63
Abcd2
KLA  ATP  ATP+KLA
 NM_011994 ATP-binding cassette, sub-family D (ALD), member 2 (Abcd2), mRNA [NM_011994] KLA .89 .87 .90 .90 .83 .74 .74
ATP 1.06 1.01 1.17 .89 .77 .80 .72
KLA/ATP .84 .84 .88 .88 .84 .74 .71
Abcd3
KLA  ATP  ATP+KLA
 NM_008991 ATP-binding cassette, sub-family D (ALD), member 3 (Abcd3), mRNA [NM_008991] KLA .90 .94 .89 .85 .75 .80 1.16
ATP 1.01 1.08 1.07 1.07 .92 .77 1.07
KLA/ATP .92 .95 .86 .93 .89 .84 .85
Abcd4
KLA  ATP  ATP+KLA
 NM_008992 ATP-binding cassette, sub-family D (ALD), member 4 (Abcd4), mRNA [NM_008992] KLA .50 .49 .50 .47 .50 .61 1.14
ATP .97 1.10 .98 .95 .68 .45 1.72
KLA/ATP .49 .52 .47 .50 .50 .51 1.11
Acaa1a
KLA  ATP  ATP+KLA
 NM_130864 acetyl-Coenzyme A acyltransferase 1A (Acaa1a), mRNA [NM_130864] KLA 1.53 1.60 1.88 2.07 2.41 2.64 1.82
ATP 1.07 .99 .98 1.10 .94 .83 1.58
KLA/ATP 1.64 1.64 1.73 1.75 1.61 1.39 1.85
Acaa1b
KLA  ATP  ATP+KLA
 NM_146230 acetyl-Coenzyme A acyltransferase 1B (Acaa1b), mRNA [NM_146230] KLA 1.52 1.66 1.93 2.04 2.32 2.51 1.83
ATP 1.04 .95 1.06 1.12 1.03 .93 1.59
KLA/ATP 1.76 1.72 1.76 1.95 1.76 1.51 1.86
Acot8
KLA  ATP  ATP+KLA
 NM_133240 acyl-CoA thioesterase 8 (Acot8), mRNA [NM_133240] KLA 1.03 1.01 .85 1.11 1.32 1.56 1.41
ATP .98 1.02 1.00 1.07 .85 .95 1.38
KLA/ATP 1.04 .89 1.01 1.18 1.03 .96 1.70
Acox1
KLA  ATP  ATP+KLA
 NM_015729 acyl-Coenzyme A oxidase 1, palmitoyl (Acox1), mRNA [NM_015729] KLA .79 .81 .78 .68 .66 .69 .82
ATP .97 1.09 .93 .90 .81 .78 1.22
KLA/ATP .81 .82 .69 .68 .59 .70 .88
Acox2
KLA  ATP  ATP+KLA
 NM_053115 acyl-Coenzyme A oxidase 2, branched chain (Acox2), mRNA [NM_053115] KLA .99 1.04 1.04 1.06 1.01 1.01 .99
ATP 1.06 1.08 .97 1.04 1.02 1.00 1.02
KLA/ATP 1.07 1.05 1.03 1.01 1.01 1.04 1.02
Acox3
KLA  ATP  ATP+KLA
 NM_030721 acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), mRNA [NM_030721] KLA .56 .56 .63 .55 .50 .48 .68
ATP 1.10 1.00 .85 .76 .87 .44 .73
KLA/ATP .61 .66 .57 .49 .57 .48 .47
Acsl1
KLA  ATP  ATP+KLA
 NM_007981 acyl-CoA synthetase long-chain family member 1 (Acsl1), mRNA [NM_007981] KLA 6.45 6.43 6.31 6.46 7.76 10.38 13.72
ATP 1.02 1.14 1.04 1.69 2.56 4.02 2.69
KLA/ATP 6.36 6.25 5.41 6.54 4.81 4.79 9.93
Acsl3
KLA  ATP  ATP+KLA
 NM_001033606 acyl-CoA synthetase long-chain family member 3 (Acsl3), transcript variant 2, mRNA [NM_001033606] KLA .29 .27 .29 .29 .30 .32 .39
ATP 1.06 .98 1.19 1.92 2.34 .67 .75
KLA/ATP .27 .26 .39 .88 1.31 .50 .24
Acsl4
KLA  ATP  ATP+KLA
 NM_207625 acyl-CoA synthetase long-chain family member 4 (Acsl4), transcript variant 1, mRNA [NM_207625] KLA 1.16 1.03 1.01 1.21 1.21 1.51 1.70
ATP .89 .88 1.64 1.60 2.24 5.91 2.42
KLA/ATP .92 1.00 1.90 1.71 1.83 3.23 3.56
Acsl5
KLA  ATP  ATP+KLA
 NM_027976 acyl-CoA synthetase long-chain family member 5 (Acsl5), mRNA [NM_027976] KLA 1.32 1.46 1.54 1.51 2.04 2.20 2.31
ATP 1.02 1.10 .89 1.03 .92 .84 .99
KLA/ATP 1.42 1.54 1.17 1.29 .97 1.11 1.35
Acsl6
KLA  ATP  ATP+KLA
 AK147421 adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1038B08 product:acyl-CoA synthetase long-chain family member 6, full insert sequence [AK147421] KLA 1.00 .97 1.02 .99 .97 1.02 1.03
ATP .97 .96 .95 .97 1.00 1.03 1.04
KLA/ATP .99 .96 1.08 .96 1.01 .96 1.00
Acsl6
KLA  ATP  ATP+KLA
 NM_001033599 acyl-CoA synthetase long-chain family member 6 (Acsl6), transcript variant 4, mRNA [NM_001033599] KLA .97 .99 1.02 1.02 1.00 1.01 .99
ATP 1.01 1.01 1.02 1.00 1.00 1.01 1.04
KLA/ATP .97 1.06 1.00 1.02 .94 1.00 1.02
Agps
KLA  ATP  ATP+KLA
 NM_172666 alkylglycerone phosphate synthase (Agps), mRNA [NM_172666] KLA .97 1.04 1.08 .98 .98 1.11 1.31
ATP 1.03 1.09 1.21 1.08 .76 .98 1.18
KLA/ATP 1.02 1.09 1.05 .90 .71 .78 1.56
Agxt
KLA  ATP  ATP+KLA
 NM_016702 alanine-glyoxylate aminotransferase (Agxt), mRNA [NM_016702] KLA 1.01 .95 .96 1.05 1.01 .98 .94
ATP .95 1.03 1.03 .99 .97 .96 1.05
KLA/ATP .94 .99 1.01 1.01 .96 .92 .96
AK087232
KLA  ATP  ATP+KLA
 AK087232 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037J19 product:unclassifiable, full insert sequence. [AK087232] KLA .99 1.12 1.03 1.03 1.01 .89 1.05
ATP 1.01 1.00 1.04 1.06 1.01 1.01 .92
KLA/ATP 1.02 1.05 .97 1.00 1.05 .84 .98
Amacr
KLA  ATP  ATP+KLA
 NM_008537 alpha-methylacyl-CoA racemase (Amacr), mRNA [NM_008537] KLA .64 .63 .59 .57 .51 .48 .77
ATP .99 .93 1.20 1.14 .69 .61 1.01
KLA/ATP .62 .65 .73 .82 .67 .67 .51
Baat
KLA  ATP  ATP+KLA
 NM_007519 bile acid-Coenzyme A: amino acid N-acyltransferase (Baat), mRNA [NM_007519] KLA .98 .99 1.01 .95 .97 .97 1.01
ATP .97 .97 1.01 .99 1.12 1.01 1.00
KLA/ATP 1.02 1.04 1.00 1.05 1.10 .99 1.01
BC051227
KLA  ATP  ATP+KLA
 NM_183170 cDNA sequence BC051227 (BC051227), mRNA [NM_183170] KLA .85 .88 .92 .86 .94 1.11 1.65
ATP 1.03 1.11 1.01 1.53 1.11 .86 1.48
KLA/ATP .99 .95 .76 1.18 .83 1.01 1.53
Cat
KLA  ATP  ATP+KLA
 NM_009804 catalase (Cat), mRNA [NM_009804] KLA .63 .67 .67 .45 .36 .21 .43
ATP 1.10 1.25 .91 1.01 .78 1.28 .84
KLA/ATP .75 .69 .43 .59 .35 .72 .87
Crat
KLA  ATP  ATP+KLA
 NM_007760 carnitine acetyltransferase (Crat), nuclear gene encoding mitochondrial protein, mRNA [NM_007760] KLA .51 .52 .51 .42 .47 .62 .83
ATP 1.04 1.15 .89 1.12 .80 .68 1.08
KLA/ATP .57 .56 .39 .51 .49 .65 .86
Crot
KLA  ATP  ATP+KLA
 NM_023733 carnitine O-octanoyltransferase (Crot), mRNA [NM_023733] KLA .62 .64 .68 .66 .66 .70 .57
ATP 1.07 1.05 .98 .90 .55 .52 .68
KLA/ATP .63 .62 .60 .59 .47 .49 .44
Dao1
KLA  ATP  ATP+KLA
 NM_010018 D-amino acid oxidase 1 (Dao1), mRNA [NM_010018] KLA 1.00 .95 1.02 1.00 .97 1.03 .99
ATP 1.00 .93 .99 .92 1.02 .98 1.03
KLA/ATP 1.00 1.01 1.05 .99 1.03 1.00 1.08
Ddo
KLA  ATP  ATP+KLA
 AK019898 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330420D20 product:similar to D-ASPARTATE OXIDASE (EC 1.4.3.1) (FRAGMENT) [Bos taurus], full insert sequence. [AK019898] KLA 1.05 .99 .99 1.07 1.04 1.00 .99
ATP .98 1.04 .94 1.05 .98 1.03 1.01
KLA/ATP 1.02 .91 .98 1.01 1.05 1.01 1.01
Ddo
KLA  ATP  ATP+KLA
 NM_027442 D-aspartate oxidase (Ddo), mRNA [NM_027442] KLA 1.03 .93 1.02 .99 .93 1.03 1.07
ATP 1.01 .94 1.13 1.02 .99 1.00 1.02
KLA/ATP 1.03 1.04 1.10 1.02 1.11 .98 1.03
Decr2
KLA  ATP  ATP+KLA
 NM_011933 2-4-dienoyl-Coenzyme A reductase 2, peroxisomal (Decr2), mRNA [NM_011933] KLA .99 1.05 1.02 1.05 1.06 1.06 1.08
ATP 1.01 1.08 .94 1.09 .87 .58 .89
KLA/ATP 1.05 1.07 .90 1.14 .85 .69 .92
Dhrs4
KLA  ATP  ATP+KLA
 NM_030686 dehydrogenase/reductase (SDR family) member 4 (Dhrs4), transcript variant 2, mRNA [NM_030686] KLA .94 1.05 1.17 .99 .96 .84 .74
ATP 1.03 1.09 1.11 1.45 1.11 .79 .88
KLA/ATP 1.10 1.17 1.19 1.38 1.09 .87 .69
Ech1
KLA  ATP  ATP+KLA
 NM_016772 enoyl coenzyme A hydratase 1, peroxisomal (Ech1), mRNA [NM_016772] KLA .79 .84 .78 .72 .66 .67 .84
ATP 1.01 1.07 1.09 1.29 .94 .49 .84
KLA/ATP .90 .84 .83 1.00 .76 .63 .72
Ehhadh
KLA  ATP  ATP+KLA
 NM_023737 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh), mRNA [NM_023737] KLA .74 .77 .80 .88 .71 .67 .74
ATP 1.02 1.06 1.04 .90 .70 .84 .83
KLA/ATP .79 .81 .80 .65 .59 .79 .55
Ephx2
KLA  ATP  ATP+KLA
 NM_007940 epoxide hydrolase 2, cytoplasmic (Ephx2), mRNA [NM_007940] KLA 1.03 .96 .96 1.03 1.02 1.03 .87
ATP .97 .95 1.09 1.08 1.00 1.06 .96
KLA/ATP .97 1.03 1.07 1.09 1.13 .98 1.00
Gnpat
KLA  ATP  ATP+KLA
 NM_010322 glyceronephosphate O-acyltransferase (Gnpat), mRNA [NM_010322] KLA .59 .61 .51 .42 .38 .45 .79
ATP .91 .88 .81 .66 .64 .39 .63
KLA/ATP .61 .54 .46 .38 .36 .34 .36
Gstk1
KLA  ATP  ATP+KLA
 AK002661 adult male kidney cDNA, RIKEN full-length enriched library, clone:0610025I19 product:GLUTATHIONE S-TRANSFERASE, MITOCHONDRIAL (EC 2.5.1.18) (GST 13-13) (GLUTATHIONE S-TRANSFERASE SUBUNIT 13) (GST CLASS-KAPPA) homolog [Rattus norvegicus], KLA 1.05 1.02 1.06 1.05 .91 .81 .60
ATP .93 .85 1.40 1.29 1.23 1.00 .72
KLA/ATP .98 1.09 1.61 1.33 1.36 .86 .62
Hacl1
KLA  ATP  ATP+KLA
 NM_019975 2-hydroxyacyl-CoA lyase 1 (Hacl1), mRNA [NM_019975] KLA .77 .75 .78 .86 .70 .72 .78
ATP .95 .94 1.00 .84 .77 .72 .80
KLA/ATP .76 .80 .84 .74 .70 .75 .62
Hao1
KLA  ATP  ATP+KLA
 AF104312 glycolate oxidase mRNA, complete cds. [AF104312] KLA .85 .89 .77 .82 .79 .79 1.13
ATP .88 .99 .95 1.90 1.11 .82 1.22
KLA/ATP .86 .81 .72 1.28 1.14 .91 1.07
Hao3
KLA  ATP  ATP+KLA
 NM_019545 hydroxyacid oxidase (glycolate oxidase) 3 (Hao3), mRNA [NM_019545] KLA 1.03 1.03 1.00 1.08 .97 .99 .94
ATP 1.04 1.01 1.03 .97 1.07 1.01 1.01
KLA/ATP 1.00 .97 1.03 .98 1.01 1.02 1.04
Hmgcl
KLA  ATP  ATP+KLA
 NM_008254 3-hydroxy-3-methylglutaryl-Coenzyme A lyase (Hmgcl), mRNA [NM_008254] KLA .37 .34 .39 .48 .63 .86 .71
ATP .87 .84 .93 .82 .69 .91 1.21
KLA/ATP .32 .33 .38 .38 .71 1.31 1.25
Hsd17b4
KLA  ATP  ATP+KLA
 NM_008292 hydroxysteroid (17-beta) dehydrogenase 4 (Hsd17b4), mRNA [NM_008292] KLA .86 .77 .82 .76 .61 .63 .59
ATP .98 .98 1.31 1.09 1.02 .80 .64
KLA/ATP .80 .86 1.04 .87 .85 .68 .54
Idh1
KLA  ATP  ATP+KLA
 NM_010497 isocitrate dehydrogenase 1 (NADP+), soluble (Idh1), transcript variant 2, mRNA [NM_010497] KLA .71 .74 .69 .70 .54 .45 .63
ATP 1.22 1.28 1.00 1.28 1.06 .62 .81
KLA/ATP .76 .81 .68 .88 .55 .47 .40
Idh2
KLA  ATP  ATP+KLA
 NM_173011 isocitrate dehydrogenase 2 (NADP+), mitochondrial (Idh2), nuclear gene encoding mitochondrial protein, mRNA [NM_173011] KLA .83 .83 .88 .94 .66 .31 .38
ATP 1.04 1.09 1.14 1.48 1.26 .39 .49
KLA/ATP .90 .92 1.04 1.10 .82 .41 .20
Mlstd1
KLA  ATP  ATP+KLA
 NM_178797 male sterility domain containing 1 (Mlstd1), mRNA [NM_178797] KLA 1.02 .96 .99 .98 .95 .99 1.01
ATP 1.01 .97 1.01 .89 .93 1.07 .97
KLA/ATP .99 1.01 1.06 .97 .93 .87 .90
Mlstd2
KLA  ATP  ATP+KLA
 AK012966 10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810402G08 product:unclassifiable, full insert sequence. [AK012966] KLA .87 .87 .78 .64 .40 .27 .33
ATP .96 1.01 1.19 .74 1.12 1.42 .65
KLA/ATP .86 .87 .88 .57 .97 1.30 .35
Mlstd2
KLA  ATP  ATP+KLA
 NM_026143 male sterility domain containing 2 (Mlstd2), transcript variant 1, mRNA [NM_026143] KLA 1.07 1.05 .99 .92 .73 .63 .69
ATP 1.08 1.15 1.07 1.09 1.24 1.59 .91
KLA/ATP 1.05 1.06 .97 .98 1.12 1.60 .78
Mlycd
KLA  ATP  ATP+KLA
 NM_019966 malonyl-CoA decarboxylase (Mlycd), nuclear gene encoding mitochondrial protein, mRNA [NM_019966] KLA .77 .70 .74 .89 .75 .81 .66
ATP 1.01 .91 1.04 .78 .38 .62 .81
KLA/ATP .66 .66 .80 .56 .44 .57 .74
Mm.13311
4
KLA  ATP  ATP+KLA
 109150413 Unknown KLA 1.05 .99 .77 1.03 1.01 1.19 1.11
ATP 1.15 1.16 .91 1.12 .86 1.04 1.28
KLA/ATP 1.00 .98 1.01 .96 .84 1.04 1.17
Mm.20615
KLA  ATP  ATP+KLA
 6755033 Unknown KLA 1.00 .88 1.00 1.62 1.60 1.85 2.25
ATP .97 .74 .90 .49 .68 2.18 1.79
KLA/ATP .82 .76 1.04 .59 .88 1.99 2.52
Mm.27978
2
KLA  ATP  ATP+KLA
 118129958 Unknown KLA 2.11 2.21 2.43 2.47 4.04 4.71 7.22
ATP 1.19 1.20 .81 1.17 1.35 2.11 3.41
KLA/ATP 2.20 2.39 1.94 3.08 2.39 3.07 6.91
Mm.29150
3
KLA  ATP  ATP+KLA
 34328333 Unknown KLA .61 .60 .60 .53 .51 .56 .69
ATP 1.05 .96 .93 .75 .81 .44 .78
KLA/ATP .66 .58 .67 .52 .58 .47 .55
Mm.38887
KLA  ATP  ATP+KLA
 31560354 Unknown KLA .77 .76 .87 .87 .76 .72 .88
ATP 1.00 .93 1.08 .89 .79 .71 .72
KLA/ATP .80 .83 1.02 .86 .71 .72 .66
Mpv17
KLA  ATP  ATP+KLA
 NM_008622 Mpv17 transgene, kidney disease mutant (Mpv17), mRNA [NM_008622] KLA .59 .56 .62 .56 .65 .65 .68
ATP 1.21 1.16 1.12 1.06 .87 .62 1.05
KLA/ATP .72 .65 .56 .57 .59 .73 .86
Mpv17l
KLA  ATP  ATP+KLA
 NM_033564 Mpv17 transgene, kidney disease mutant-like (Mpv17l), mRNA [NM_033564] KLA .93 .82 .75 .82 .82 1.30 1.22
ATP .95 1.03 1.08 .85 .69 .58 1.00
KLA/ATP .76 .78 .90 .78 .69 .70 .73
Mvk
KLA  ATP  ATP+KLA
 NM_023556 mevalonate kinase (Mvk), mRNA [NM_023556] KLA .87 .90 .89 .91 .90 .94 .99
ATP .91 .79 .56 .59 .35 .47 1.40
KLA/ATP .89 .74 .56 .61 .43 .43 .65
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Nudt12
KLA  ATP  ATP+KLA
 NM_026497 nudix (nucleoside diphosphate linked moiety X)-type motif 12 (Nudt12), mRNA [NM_026497] KLA 1.01 .97 .94 .91 .85 .86 .94
ATP 1.00 1.01 1.02 .89 .82 .90 1.01
KLA/ATP .91 .98 .96 .89 .79 .87 1.02
Nudt19
KLA  ATP  ATP+KLA
 NM_033080 nudix (nucleoside diphosphate linked moiety X)-type motif 19 (Nudt19), mRNA [NM_033080] KLA 1.08 1.04 1.19 1.18 .97 1.18 1.14
ATP 1.09 .94 1.07 .82 .64 .57 .77
KLA/ATP 1.05 1.08 1.32 .99 .98 .78 .42
Paox
KLA  ATP  ATP+KLA
 NM_153783 polyamine oxidase (exo-N4-amino) (Paox), mRNA [NM_153783] KLA .47 .42 .37 .43 .38 .52 .55
ATP 1.08 .94 1.25 1.01 .72 .30 .68
KLA/ATP .42 .41 .53 .41 .37 .38 .48
Peci
KLA  ATP  ATP+KLA
 NM_011868 peroxisomal delta3, delta2-enoyl-Coenzyme A isomerase (Peci), transcript variant 2, mRNA [NM_011868] KLA 1.29 1.20 1.14 1.30 1.02 1.11 1.17
ATP .86 .81 1.05 .76 .62 .67 .59
KLA/ATP 1.03 1.04 1.34 1.01 .93 .89 .67
Pecr
KLA  ATP  ATP+KLA
 NM_023523 peroxisomal trans-2-enoyl-CoA reductase (Pecr), mRNA [NM_023523] KLA .99 1.01 .91 .91 .68 .46 .48
ATP .94 .90 1.34 1.29 1.06 .56 .28
KLA/ATP .92 1.06 1.37 1.20 1.06 .65 .26
Pex1
KLA  ATP  ATP+KLA
 AK087687 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330005K07 product:hypothetical protein, full insert sequence. [AK087687] KLA 1.30 1.27 1.28 1.25 1.20 1.01 .85
ATP 1.16 1.11 1.27 1.51 1.46 1.22 .83
KLA/ATP 1.30 1.42 1.61 1.69 1.49 1.13 .91
Pex1
KLA  ATP  ATP+KLA
 NM_027777 peroxisome biogenesis factor 1 (Pex1), mRNA [NM_027777] KLA .94 .89 .98 .88 .93 .97 .85
ATP 1.01 1.09 1.26 1.97 1.61 .98 .92
KLA/ATP .95 1.01 1.14 1.93 1.92 1.25 .86
Pex10
KLA  ATP  ATP+KLA
 NM_001042407 peroxisome biogenesis factor 10 (Pex10), mRNA [NM_001042407] KLA .68 .74 .68 .67 .94 1.11 1.16
ATP 1.10 1.19 .90 .97 .73 .79 1.38
KLA/ATP .80 .70 .73 .67 .65 .82 1.14
Pex11a
KLA  ATP  ATP+KLA
 NM_011068 peroxisomal biogenesis factor 11a (Pex11a), mRNA [NM_011068] KLA .94 .93 .95 1.64 1.62 1.85 2.36
ATP .85 .70 .81 .49 .66 2.15 1.76
KLA/ATP .75 .75 .92 .54 .84 1.99 2.52
Pex11b
KLA  ATP  ATP+KLA
 NM_011069 peroxisomal biogenesis factor 11b (Pex11b), mRNA [NM_011069] KLA .76 .75 .79 .92 .85 .88 .91
ATP 1.00 .94 1.04 .76 .48 .84 1.03
KLA/ATP .79 .77 .91 .68 .48 .67 .89
Pex11c
KLA  ATP  ATP+KLA
 AK029391 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429A22 product:unclassifiable, full insert sequence. [AK029391] KLA .85 .89 .88 .90 .95 .93 .94
ATP .96 .94 .87 .83 .95 .91 .88
KLA/ATP .86 .86 .87 .93 .92 .92 .92
Pex11c
KLA  ATP  ATP+KLA
 NM_026951 peroxisomal biogenesis factor 11c (Pex11c), mRNA [NM_026951] KLA 1.10 1.05 1.05 1.14 1.06 1.06 .94
ATP .98 .97 1.32 1.26 1.05 .97 1.00
KLA/ATP 1.06 1.18 1.50 1.41 1.40 1.19 1.19
Pex12
KLA  ATP  ATP+KLA
 NM_134025 peroxisomal biogenesis factor 12 (Pex12), mRNA [NM_134025] KLA .93 .96 .92 .90 .91 1.06 1.22
ATP .96 .84 .74 .83 1.13 1.14 1.04
KLA/ATP .95 .88 .72 .80 .95 .97 .93
Pex13
KLA  ATP  ATP+KLA
 AK037872 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130057L17 product:peroxisomal biogenesis factor 13, full insert sequence. [AK037872] KLA 1.15 1.14 .91 .98 1.07 1.23 .85
ATP .71 .59 .54 .65 2.08 1.57 1.05
KLA/ATP .89 .75 .69 .74 1.65 1.21 1.34
Pex13
KLA  ATP  ATP+KLA
 NM_023651 peroxisomal biogenesis factor 13 (Pex13), mRNA [NM_023651] KLA 1.27 1.19 1.55 1.33 .95 1.29 1.07
ATP 1.00 .92 1.08 .74 1.73 1.94 1.40
KLA/ATP 1.23 1.17 1.62 .98 1.42 1.52 1.97
Pex14
KLA  ATP  ATP+KLA
 NM_019781 peroxisomal biogenesis factor 14 (Pex14), mRNA [NM_019781] KLA 1.39 1.27 1.31 1.59 1.46 1.47 1.21
ATP 1.08 1.01 1.40 1.34 1.06 1.63 1.32
KLA/ATP 1.22 1.27 1.90 1.76 1.56 1.70 1.87
Pex16
KLA  ATP  ATP+KLA
 NM_145122 peroxisome biogenesis factor 16 (Pex16), mRNA [NM_145122] KLA 1.33 1.32 1.17 1.32 1.77 1.81 2.57
ATP 1.11 1.12 .84 1.09 .95 1.39 1.77
KLA/ATP 1.25 1.38 1.01 1.34 .93 1.46 2.79
Pex19
KLA  ATP  ATP+KLA
 NM_023041 peroxisome biogenesis factor 19 (Pex19), mRNA [NM_023041] KLA 1.11 1.15 1.14 1.17 1.20 1.11 1.19
ATP 1.11 1.17 .95 1.34 .99 .91 1.20
KLA/ATP 1.16 1.21 1.01 1.32 .89 1.01 1.39
Pex2
KLA  ATP  ATP+KLA
 NM_008994 peroxisome biogenesis factor 2 (Pex2), mRNA [NM_008994] KLA 1.03 1.08 1.10 1.00 1.09 1.09 1.23
ATP .90 .87 .81 .77 .52 .78 .98
KLA/ATP .88 .91 .78 .77 .59 .76 .83
Pex26
KLA  ATP  ATP+KLA
 NM_028730 peroxisome biogenesis factor 26 (Pex26), mRNA [NM_028730] KLA 1.05 1.14 1.21 1.07 .81 .95 .86
ATP 1.04 1.04 .68 .60 .57 1.04 1.16
KLA/ATP 1.13 1.02 .83 .71 .62 .77 .82
Pex3
KLA  ATP  ATP+KLA
 AK083778 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130007G21 product:peroxisomal biogenesis factor 3, full insert sequence. [AK083778] KLA 1.08 1.00 .97 1.03 1.04 1.02 1.03
ATP 1.03 1.09 1.00 .91 1.07 1.02 .99
KLA/ATP .98 .97 1.02 .99 1.00 .97 .95
Pex3
KLA  ATP  ATP+KLA
 NM_019961 peroxisomal biogenesis factor 3 (Pex3), mRNA [NM_019961] KLA 1.17 1.27 1.26 1.22 1.14 1.12 1.33
ATP 1.01 1.02 1.06 1.01 .73 .74 .97
KLA/ATP 1.18 1.16 1.10 1.12 .85 .79 .84
Pex5
KLA  ATP  ATP+KLA
 NM_008995 peroxisome biogenesis factor 5 (Pex5), transcript variant 1, mRNA [NM_008995] KLA 1.12 1.14 1.18 1.08 1.08 1.02 1.06
ATP 1.04 1.30 1.07 1.43 1.46 1.76 1.00
KLA/ATP 1.22 1.22 .98 1.27 1.07 1.72 1.27
Pex6
KLA  ATP  ATP+KLA
 NM_145488 peroxisomal biogenesis factor 6 (Pex6), mRNA [NM_145488] KLA .77 .83 .79 .72 .92 .94 .92
ATP 1.12 1.16 .96 1.14 .91 .59 .72
KLA/ATP .93 .89 .72 .86 .75 .76 .95
Pex7
KLA  ATP  ATP+KLA
 NM_008822 peroxisome biogenesis factor 7 (Pex7), mRNA [NM_008822] KLA 1.06 1.18 1.07 1.08 .91 .79 .82
ATP .97 .86 .78 .60 .47 .46 .64
KLA/ATP 1.08 1.07 .90 .80 .59 .49 .49
Phyh
KLA  ATP  ATP+KLA
 NM_010726 phytanoyl-CoA hydroxylase (Phyh), mRNA [NM_010726] KLA 1.75 1.70 1.93 2.30 2.40 2.97 1.43
ATP .91 .95 1.20 1.35 .87 .53 1.13
KLA/ATP 1.51 1.70 2.26 2.21 1.74 1.65 1.58
Pipox
KLA  ATP  ATP+KLA
 NM_008952 pipecolic acid oxidase (Pipox), mRNA [NM_008952] KLA .97 .94 1.00 1.00 .98 1.06 1.01
ATP 1.04 1.01 1.03 1.03 1.06 .93 1.01
KLA/ATP 1.03 1.12 1.07 1.06 .98 1.07 .97
Pmvk
KLA  ATP  ATP+KLA
 NM_026784 phosphomevalonate kinase (Pmvk), mRNA [NM_026784] KLA .89 .91 .96 .99 .92 .78 .88
ATP 1.13 .98 1.07 1.10 .70 .51 1.19
KLA/ATP .94 .95 1.06 .91 .80 .44 .53
Prdx1
KLA  ATP  ATP+KLA
 NM_011034 peroxiredoxin 1 (Prdx1), mRNA [NM_011034] KLA 1.10 1.11 1.10 .93 1.26 1.09 1.71
ATP 1.13 1.18 .93 .82 2.27 5.72 4.62
KLA/ATP 1.19 1.21 .89 1.05 1.55 3.56 5.35
Prdx5
KLA  ATP  ATP+KLA
 NM_012021 peroxiredoxin 5 (Prdx5), nuclear gene encoding mitochondrial protein, mRNA [NM_012021] KLA 2.08 2.13 2.52 2.57 3.75 4.64 6.44
ATP 1.11 1.11 1.01 1.41 1.59 2.33 2.94
KLA/ATP 2.18 2.35 2.45 3.32 3.08 3.51 6.53
Pxmp2
KLA  ATP  ATP+KLA
 NM_008993 peroxisomal membrane protein 2 (Pxmp2), mRNA [NM_008993] KLA 1.02 1.09 1.40 1.49 1.33 1.17 .66
ATP .96 .89 1.18 1.18 1.05 .88 .85
KLA/ATP 1.00 .99 1.36 1.15 1.27 .93 .81
Pxmp4
KLA  ATP  ATP+KLA
 NM_021534 peroxisomal membrane protein 4 (Pxmp4), mRNA [NM_021534] KLA .71 .65 .69 .78 .89 .99 .67
ATP 1.07 .99 1.19 1.17 .75 .43 .69
KLA/ATP .72 .68 .77 .78 .60 .52 .80
Scp2
KLA  ATP  ATP+KLA
 NM_011327 sterol carrier protein 2, liver (Scp2), mRNA [NM_011327] KLA .88 .85 .85 .77 .71 .68 .66
ATP 1.03 1.13 1.25 1.38 1.10 .63 .47
KLA/ATP .85 .88 .91 1.06 .83 .58 .38
Slc25a17
KLA  ATP  ATP+KLA
 NM_011399 solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17 (Slc25a17), nuclear gene encoding mitochondrial protein, mRNA [NM_011399] KLA 1.95 1.95 1.91 1.70 1.12 .82 .86
ATP 1.04 1.06 1.26 1.26 1.05 .97 .86
KLA/ATP 1.83 2.09 2.34 2.28 1.55 1.04 .77
Slc27a2
KLA  ATP  ATP+KLA
 AK038847 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230068F22 product:solute carrier family 27 (fatty acid transporter), member 2, full insert sequence. [AK038847] KLA .99 .98 1.13 .98 1.04 .98 .99
ATP .98 1.05 1.32 .96 .96 1.07 1.01
KLA/ATP 1.06 .98 1.02 1.01 .96 1.03 1.07
Slc27a2
KLA  ATP  ATP+KLA
 NM_011978 solute carrier family 27 (fatty acid transporter), member 2 (Slc27a2), mRNA [NM_011978] KLA 1.26 1.26 1.24 1.22 1.14 1.00 .85
ATP .98 1.06 1.04 .95 .99 1.07 1.06
KLA/ATP 1.24 1.16 1.34 1.12 1.01 .97 1.11
Sod1
KLA  ATP  ATP+KLA
 AK080908 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430204E11 product:superoxide dismutase 1, soluble, full insert sequence [AK080908] KLA .70 .66 .60 .58 .66 .71 .86
ATP .93 .82 .78 .90 1.22 .91 .84
KLA/ATP .66 .64 .71 .75 .74 .73 .77
Sod1
KLA  ATP  ATP+KLA
 NM_011434 superoxide dismutase 1, soluble (Sod1), mRNA [NM_011434] KLA .71 .80 .65 .90 .69 .53 .53
ATP 1.03 .84 1.06 .96 1.27 1.34 .66
KLA/ATP .78 .79 1.12 .77 .96 .82 .52
Sod2
KLA  ATP  ATP+KLA
 NM_013671 superoxide dismutase 2, mitochondrial (Sod2), nuclear gene encoding mitochondrial protein, mRNA [NM_013671] KLA 8.75 8.12 8.63 11.76 12.02 16.67 15.62
ATP .99 .93 1.09 1.21 3.52 13.11 5.27
KLA/ATP 8.15 8.16 9.97 8.73 11.03 12.81 16.97
Xdh
KLA  ATP  ATP+KLA
 NM_011723 xanthine dehydrogenase (Xdh), mRNA [NM_011723] KLA 1.82 1.90 2.33 2.06 2.49 2.56 1.77
ATP 1.02 1.15 .98 1.10 1.06 1.02 1.42
KLA/ATP 2.00 2.00 2.02 2.11 1.27 1.56 1.92